New injection recommendations for patients with diabetesDAVIDSON, Jaime A.Diabetes & metabolism. 2010, Vol 36, issn 1262-3636, 29 p., NS2Serial Issue

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? YesDAVIDSON, Jaime A; PARKIN, Christopher G.Diabetes care. 2009, Vol 32, Num 3, pp 5331-5333, issn 0149-5992, 3 p., SUPConference Paper

New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's viewDAVIDSON, Jaime A; WILKINSON, Alan.Diabetes care. 2004, Vol 27, Num 3, pp 805-812, issn 0149-5992, 8 p.Article

Tolerability profile of metformin/glibenclamide combination tablets (glucovance®). A new treatment for the management of type 2 diabetes mellitusDAVIDSON, Jaime A; SCHEEN, André J; HOWLETT, Harry C. S et al.Drug safety. 2004, Vol 27, Num 15, pp 1205-1216, issn 0114-5916, 12 p.Article

Cardiovascular Disease in Diabetes Mellitus Risk Factors and Medical TherapySZUSZKIEWICZ-GARCIA, Magdalene M; DAVIDSON, Jaime A.Endocrinology and metabolism clinics of North America (Print). 2014, Vol 43, Num 1, issn 0889-8529, 25-40, vii [17 p.]Article

The Third Injection Technique Workshop In Athens (TITAN)FRID, A; HIRSCH, L; GASPAR, R et al.Diabetes & metabolism. 2010, Vol 36, issn 1262-3636, S19-S29, NS2Article

Postprandial glucose regulation : New data and new implicationsLEITER, Lawrence A; CERIELLO, Antonio; DAVIDSON, Jaime A et al.Clinical therapeutics. 2005, Vol 27, pp S42-S56, issn 0149-2918, SUPBArticle